Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| 10-K/A | 10-K/A | 10-K | 10-K | S-1 |
Total revenues | 134.6 | 100.4 | 55,430.8 | 28,717.3 | 5,650.2 |
Revenue growth | 34.0% | -99.8% | 93.0% | 408.2% | |
Cost of goods sold | 0.0 | 0.0 | 45,594.2 | 23,221.4 | 4,477.7 |
Gross profit | 134.6 | 100.4 | 9,836.6 | 5,495.9 | 1,172.6 |
Gross margin | 100.0% | 100.0% | 17.7% | 19.1% | 20.8% |
Selling, general and administrative [+] | | | 1,173.3 | 764.2 | 249.7 |
Sales and marketing | | | 146.5 | 2.6 | 19.4 |
General and administrative | 0.0 | 0.0 | 1,026.9 | 761.6 | 230.3 |
Research and development | | | | 88.9 | 0.0 |
Other operating expenses | 134.6 | 100.4 | 11.3 | -2.7 | 42.0 |
EBITDA | | | | | 880.8 |
EBITDA margin | 0.0% | 0.0% | | | 15.6% |
Depreciation and amortization | | | | | 0.0 |
EBIT [+] | 0.0 | 0.0 | 8,652.0 | 4,645.5 | 880.8 |
EBIT growth | | -100.0% | 86.2% | 427.4% | |
EBIT margin | 0.0% | 0.0% | 15.6% | 16.2% | 15.6% |
Non-recurring items | | | -11.3 | -0.3 | |
Interest expense, net [+] | | | 400.1 | 262.9 | 11.1 |
Interest expense | | | 409.8 | 266.4 | 11.6 |
Interest income | | | 9.8 | 3.5 | 0.5 |
Other income (expense), net [+] | | | -22.2 | 0.0 | 83.6 |
Gain (loss) on sale of assets | | | | | -48.2 |
Pre-tax income | 0.0 | 0.0 | 8,241.0 | 4,382.9 | 953.3 |
Income taxes | 0.0 | 0.0 | 2,132.6 | 1,515.5 | 314.6 |
Tax rate | | | 25.9% | 34.6% | 33.0% |
Net income | 0.0 | 0.0 | 6,108.5 | 2,867.4 | 638.7 |
Net margin | 0.0% | 0.0% | 11.0% | 10.0% | 11.3% |
|
Basic EPS [+] | | | $0.00 | $0.00 | $0.04 |
Growth | | | | -100.0% | |
Diluted EPS [+] | | | $0.00 | $0.00 | $0.04 |
Growth | | | | -100.0% | |
|
Shares outstanding (basic) [+] | | | 5,896.7 | 5,896.7 | 14,515.0 |
Growth | | | 0.0% | -59.4% | |
Shares outstanding (diluted) [+] | | | 5,896.7 | 5,896.7 | 14,515.0 |
Growth | | | 0.0% | -59.4% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|